Back to Search
Start Over
Oral Vaccines Against Cholera
- Source :
- Clinical Infectious Diseases. 52:1343-1349
- Publication Year :
- 2011
- Publisher :
- Oxford University Press (OUP), 2011.
-
Abstract
- The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global burden has returned cholera to the forefront of global public health discussions. Improved water and sanitation should continue to be the mainstays of cholera-prevention efforts, but major improvements are a far-off goal for much of the cholera-affected developing world. The advent of safe and effective, new-generation oral vaccines against cholera has created renewed interest in the use of vaccines as a tool to control cholera.
- Subjects :
- Microbiology (medical)
medicine.medical_specialty
Sanitation
Administration, Oral
El Tor
Antibiotic resistance
Cholera
Environmental health
Pandemic
medicine
Humans
Developing Countries
Pandemics
Serogroup O1
biology
business.industry
Public health
Cholera Vaccines
medicine.disease
biology.organism_classification
Virology
Infectious Diseases
Communicable Disease Control
Cholera vaccine
business
Subjects
Details
- ISSN :
- 15376591 and 10584838
- Volume :
- 52
- Database :
- OpenAIRE
- Journal :
- Clinical Infectious Diseases
- Accession number :
- edsair.doi.dedup.....b0acd5730d544e38c38da5c83f5510b6
- Full Text :
- https://doi.org/10.1093/cid/cir141